Kodiak Sciences Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering, advancing, and bringing to market treatments for various conditions affecting the retina. Their primary drug candidate, KSI-301,…
Sector
Healthcare
Exchange
NASDAQ
Country
US
Kodiak Sciences (KOD) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Kodiak Sciences (KOD) Analysis Tools & Insights
Income Statement
Capital Return
How this company returns cash to shareholders — buybacks, dividends, and stock splits.